← Open Payments lookup

ANITA BELUE: Open Payments

NPI 1700391489 · INMAN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,197 in 64 payments from 10 companies in 2025. Trend: 2023 $1,617 · 2024 $1,344 · 2025 $1,197

Food & beverage: $1,197
CompanyPaymentsAmount
ABBVIE INC.32$407
AstraZeneca Pharmaceuticals LP8$331
Novo Nordisk Inc14$276
Amgen Inc.3$45
Lilly USA, LLC2$42
Braeburn Inc.1$24
Abbott Laboratories1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Indivior Inc.1$18
PFIZER INC.1$15

Products named: VRAYLAR, FARXIGA, Ozempic, AIRSUPRA, QULIPTA, Rybelsus, UBRELVY, JARDIANCE.

Industry payments across SC — which companies pay providers there.